KOBO BIOTECH LIMITED Share Price
₹ 8.56
-₹0.17 (-1.95%)
1D
Last updated 28 Jul, 2026, 15:15 IST
KOBO BIOTECH LIMITED Share Price Today
As of 29 Jul 2026, KOBO BIOTECH LIMITED share price is ₹8.56. The stock opened at ₹8.56, compared to its previous close of ₹8.73. During today's trading session, KOBO BIOTECH LIMITED share price moved in the range of ₹8.56 to ₹8.60, with an average price of ₹8.58 for the day. Looking at its last 52-week, the stock has touched a low of ₹1.99 and a high of ₹9.99.
₹8.56
1.95% down today
₹8.60
1D LOW1D HIGH
Stock Performance
OutperformingBeat Nifty by 21.66 % in last 1 monthKOBO BIOTECH LIMITED Returns Calculator
If you would've invested
₹
₹1,000₹1Cr
Historical Returns
1 Year
₹18,36,910+₹13,36,910 (+267.38%)
3 Year
₹17,83,333+₹12,83,333 (+256.67%)
5 Year
₹7,29,131+₹2,29,131 (+45.83%)
Market Overview
Fundamentals
Financials
Technicals
About
Events
FAQs
Open
₹8.56
High
₹8.60
Low
₹8.56
Prev. close
₹8.73
Volume
1,646
Average traded price
₹8.56
Last traded time
03:15:00 28 Jul
Last traded quantity
5
₹8.56₹8.90
Circuit LowCircuit High
₹1.99₹9.99
52-Week Low52-Week High
Circuit
LH
₹8.56
₹8.90
52-week
LH
₹1.99
₹9.99
KOBO BIOTECH LIMITED Shareholder Returns
1 day
-1.95%
1 week
-9.32%
1 month
+13.83%
1 year
+227.97%
3 years
+270.56%
5 years
+39.64%
KOBO BIOTECH LIMITED Share Price History
Day
Open / Close
Change %
28 Jul 26
₹8.56 / ₹8.56
-1.95%
27 Jul 26
₹8.73 / ₹8.73
-1.91%
24 Jul 26
₹8.90 / ₹8.90
-1.98%
23 Jul 26
₹9.08 / ₹9.08
-1.94%
22 Jul 26
₹9.26 / ₹9.26
-1.91%
21 Jul 26
₹9.44 / ₹9.44
-1.97%
20 Jul 26
₹9.99 / ₹9.63
-1.93%
17 Jul 26
₹9.44 / ₹9.82
+1.97%
Show more
Mkt Cap Cr
60.53
P/E
0.00
P/B
1.14
ROE
0.00%
D/E
0.00
ROCE
0.00%
Div. Yield
0.00%
EPS(TTM)
0.00
Turnover
0.00
EV/EBITDA
0.00
Net Margin
0.00%
Op. Margin
0.00%
ROA
-13.19%
Quick Ratio
0.14
Curr. Ratio
0.23
Mkt Cap Cr
60.53
P/E
0.00
P/B
1.14
ROE
0.00%
D/E
0.00
ROCE
0.00%
Div. Yield
0.00%
EPS(TTM)
0.00
Turnover
0.00
EV/EBITDA
0.00
Net Margin
0.00%
Op. Margin
0.00%
ROA
-13.19%
Quick Ratio
0.14
Curr. Ratio
0.23
Based on fundamentals, this stock's
5/5
Performance
Excellent
Kobo Biotech outperforming all market indices
3/5
Valuation
Fairly Valued
Kobo Biotech appears to be fairly valued compared to its peers
1/5
Earnings
Very Poor
Kobo Biotech revenue, operating profits and net profits have been degrowing
Peer Comparison
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,73,509.00 | 36.73 | 5.05 | 14.85% | 0.55 | 18.72% | 18.85 | 0.91% | 0.56 | 10.90 |
| Divis Laboratories | 1,96,881.00 | 61.36 | 9.40 | 16.19% | 0.00 | 21.00% | 9.43 | 0.50% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,90,832.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,13,894.00 | 33.94 | 3.31 | 11.27% | 0.00 | 14.95% | 423.36 | 0.92% | 0.45 | 43.52 |
| Zydus Lifesciences | 1,10,523.00 | 17.39 | 3.23 | 19.69% | 0.35 | 20.30% | 3.70 | 0.11% | 0.39 | 35.38 |
| Lupin | 1,09,493.00 | 19.83 | 4.71 | 27.01% | 0.03 | 27.44% | 3.51 | 0.78% | 0.61 | 129.18 |
| Mankind Pharma | 1,05,357.00 | 1.05 | 0.12 | 12.65% | 0.42 | 12.97% | 5.05 | 0.05% | 0.54 | 49.37 |
| Dr. Reddy's Laboratories | 96,062.80 | 30.18 | 2.52 | 11.07% | 0.18 | 12.54% | 377.96 | 0.70% | 0.41 | 38.68 |
| Laurus Labs | 92,612.30 | 84.91 | 17.47 | 16.77% | 0.40 | 16.14% | 97.21 | 0.12% | 0.67 | 13.72 |
| Aurobindo Pharma | 89,954.50 | 25.68 | 2.37 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
KOBO BIOTECH LIMITED Financials
Full statement
Income Statement · Consolidated
| Particulars | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 |
|---|---|---|---|---|
| Revenue | ₹103.19 | ₹403.66 | ₹403.66 | ₹287.26 |
| Other Income | ₹0.25 | ₹0.37 | ₹0.37 | ₹0.23 |
| Total Revenue | ₹103.44 | ₹404.02 | ₹404.02 | ₹287.50 |
| Total Expenses | ₹137.71 | ₹389.15 | ₹389.15 | ₹269.83 |
| Profit Before Tax | -₹34.27 | ₹14.87 | ₹14.87 | ₹17.67 |
| Tax | ₹0.54 | ₹1.21 | ₹1.21 | ₹2.00 |
| Profit After Tax | -₹34.82 | ₹13.67 | ₹13.67 | ₹15.67 |
| EPS - Basic | -₹15.47 | ₹6.22 | ₹6.22 | ₹6.72 |
| EPS - Diluted | -₹15.47 | ₹6.22 | ₹6.22 | ₹6.72 |
Cash Flow · Consolidated
| Particulars | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 |
|---|---|---|---|---|
| Profit before tax | -₹34.27 | ₹14.87 | ₹14.87 | ₹17.67 |
| Income before WC changes | -₹0.67 | ₹43.24 | ₹43.24 | ₹49.11 |
| Change in Assets | ₹4.12 | -₹1.73 | -₹1.73 | -₹69.41 |
| Change in Liabilities | ₹3.82 | -₹3.00 | -₹3.00 | ₹86.19 |
| Change in WC | ₹7.94 | -₹4.74 | -₹4.74 | ₹16.78 |
| Cash flow from Operations | ₹6.72 | ₹36.72 | ₹36.72 | ₹63.89 |
| Cash flow from Investing | -₹4.71 | -₹6.99 | -₹6.99 | -₹14.43 |
| Cash flow from Financing | -₹12.85 | -₹38.39 | -₹38.39 | -₹26.82 |
| Total Cash Flow | -₹10.84 | -₹8.66 | -₹8.66 | ₹22.64 |
| Cash (Start of the year) | ₹16.48 | ₹25.13 | ₹25.13 | ₹2.49 |
| Cash (End of the year) | ₹5.64 | ₹16.48 | ₹16.48 | ₹25.13 |
Balance Sheet · Consolidated
| Particulars | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 |
|---|---|---|---|---|
| Non-Current Assets | ₹105.77 | ₹110.69 | ₹110.69 | ₹113.66 |
| Current Assets | ₹289.81 | ₹300.99 | ₹300.99 | ₹231.95 |
| Total Assets | ₹395.58 | ₹411.68 | ₹411.68 | ₹345.61 |
| Current Liabilities | ₹263.52 | ₹256.48 | ₹256.48 | ₹184.62 |
| Net Current Asset | ₹26.28 | ₹44.51 | ₹44.51 | ₹47.33 |
| Non-Current Liabilities | ₹78.98 | ₹67.30 | ₹67.30 | ₹85.34 |
| Equity Capital | ₹53.08 | ₹87.89 | ₹87.89 | ₹75.66 |
| Total Equity & Liabilities | ₹395.58 | ₹411.68 | ₹411.68 | ₹345.61 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 |
| Other Income | ₹0.08 | ₹0.02 | ₹0.02 | ₹0.02 |
| Total Revenue | ₹0.08 | ₹0.02 | ₹0.02 | ₹0.02 |
| Total Expenses | ₹5.31 | ₹4.94 | ₹5.57 | ₹15.24 |
| Profit Before Tax | -₹5.23 | -₹4.93 | -₹5.55 | -₹15.23 |
| Tax | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 |
| Profit After Tax | -₹5.23 | -₹4.93 | -₹5.55 | -₹15.23 |
| EPS - Basic | -₹2.20 | -₹2.07 | -₹2.33 | -₹6.39 |
| EPS - Diluted | -₹2.20 | -₹2.07 | -₹2.33 | -₹6.39 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | -₹5.23 | -₹4.93 | -₹5.55 | -₹15.23 |
| Income before WC changes | -₹1.16 | -₹0.86 | -₹1.48 | -₹10.49 |
| Change in Assets | -₹0.09 | -₹0.08 | -₹0.22 | ₹120.27 |
| Change in Liabilities | ₹5.43 | ₹1.14 | ₹2.57 | -₹16.03 |
| Change in WC | ₹5.33 | ₹1.06 | ₹2.36 | ₹104.24 |
| Cash flow from Operations | ₹4.18 | ₹0.20 | ₹0.87 | ₹93.76 |
| Cash flow from Investing | ₹0.00 | ₹0.00 | ₹0.00 | ₹25.09 |
| Cash flow from Financing | ₹0.00 | -₹0.15 | -₹0.87 | -₹120.28 |
| Total Cash Flow | ₹4.18 | ₹0.05 | ₹0.00 | -₹1.43 |
| Cash (Start of the year) | ₹0.18 | ₹0.13 | ₹0.13 | ₹1.56 |
| Cash (End of the year) | ₹4.36 | ₹0.18 | ₹0.13 | ₹0.13 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹29.44 | ₹33.52 | ₹37.59 | ₹41.66 |
| Current Assets | ₹42.15 | ₹37.88 | ₹37.74 | ₹37.53 |
| Total Assets | ₹71.59 | ₹71.39 | ₹75.33 | ₹79.19 |
| Current Liabilities | ₹173.25 | ₹167.82 | ₹165.88 | ₹163.31 |
| Net Current Asset | -₹131.10 | -₹129.94 | -₹128.14 | -₹125.79 |
| Non-Current Liabilities | ₹36.48 | ₹36.48 | ₹37.43 | ₹38.30 |
| Equity Capital | -₹138.14 | -₹132.91 | -₹127.98 | -₹122.43 |
| Total Equity & Liabilities | ₹71.59 | ₹71.39 | ₹75.33 | ₹79.19 |
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
8.56
135719
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 135719
Buy orders: 0%
Sell orders: 100%
30 levels of bid & ask depth
Supply & Demand Zones
Bearish
2
Neutral
3
Bullish
3
Slightly Bullish
by SEBI experts available for this stock
Earn more using advisory
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
59.71
Neutral
ATR (14)
0.21
Neutral
STOCH(9,6)
0
Bullish
STOCH RSI (14)
0
Bullish
ADX(9)
61.73
Bearish
UO(9)
37.43
Neutral
ROC(12)
-2.13
Bearish
WillR(14)
-100
Bullish
Period
Simple value
Exponential vaue
5D
9.08
9.03
10D
9.36
9.1
20D
8.94
8.71
50D
6.66
7.1
100D
4.61
5.5
About KOBO BIOTECH LIMITED
ISIN
INE881A01015
Sector Market Cap
₹ 60.53 Cr
Kobo Biotech Limited is an India-based company. The Company's business segment is manufacturing active pharmaceutical ingredients (APIs)/bulk drugs. The Company is in the corporate insolvency resolution process.
KOBO BIOTECH LIMITED Financial Highlights
- Revenue: KOBO BIOTECH LIMITED reported revenue of ₹103.44 crore in FY14 vs ₹404.03 crore in FY13. It showed a decrease of 74.40% on a yearly basis.
- Operating Profit: KOBO BIOTECH LIMITED reported an operating loss of ₹34.27 crore in FY14 vs ₹14.88 crore in FY13. It showed a decrease of 330.31% on a year-on-year basis.
- Net Profit: KOBO BIOTECH LIMITED reported a net loss of ₹34.82 crore in FY14 vs ₹13.67 crore in FY13. It showed a decrease of 354.72% on a yearly basis.
KOBO BIOTECH LIMITED Quarterly Result Highlights
- KOBO BIOTECH LIMITED reported revenue of ₹0.02 crore in Jun 2024, compared with ₹0.00 crore in Mar 2024.
- KOBO BIOTECH LIMITED reported an operating loss of ₹1.33 crore in Jun 2024, compared with ₹1.26 crore in Mar 2024, representing a decrease of 5.56% on a quarter-on-quarter (QoQ) basis.
- KOBO BIOTECH LIMITED reported a loss of ₹1.33 crore in Jun 2024, compared with ₹1.26 crore in Mar 2024, reflecting a decrease of 5.56% on a QoQ basis.
- The earnings per share (EPS) of KOBO BIOTECH LIMITED stood at ₹2.20 during Jun 2024.
Promoters
44.95%
FII
0.00%
Other DII
0.00%
Retail and other
55.05%
Mutual funds
0.00%
Foreign institutions - FII
Compare against other stocks
KOBO BIOTECH LIMITED
Pharmaceuticals
Add Stock
Add Another
Similar Stocks
Sun Pharmaceutical Industries
₹1977.20
+3.70 (0.19%)
Divis Laboratories
₹7437.65
+21.30 (0.29%)
Torrent Pharmaceuticals
₹4895.00
-122.05 (-2.43%)
Cipla
₹1444.65
+34.80 (2.47%)
Zydus Lifesciences
₹1101.65
-6.35 (-0.57%)
Lupin
₹2398.45
-11.45 (-0.48%)
Mankind Pharma
₹2628.00
+76.95 (3.02%)
Dr. Reddy's Laboratories
₹1135.65
-15.25 (-1.33%)
Laurus Labs
₹1758.00
+43.75 (2.55%)
Aurobindo Pharma
₹1559.10
+10.30 (0.67%)
Top Gainers Today
FAQs on KOBO BIOTECH LIMITED Share Price
What is KOBO BIOTECH LIMITED share price today?
KOBO BIOTECH LIMITED share price is ₹8.56 as on 28 Jul, 2026, 15:15 IST.
How has the KOBO BIOTECH LIMITED share price performed in the past?
In the last 1 year, KOBO BIOTECH LIMITED delivered a return of 227.97%. The KOBO BIOTECH LIMITED share price hit a high of ₹9.99 and low of ₹1.99.
How much is the Mutual Fund shareholding in KOBO BIOTECH LIMITED shares?
The Mutual Fund Shareholding in KOBO BIOTECH LIMITED was 0.00% at the end of Jun 2026.
What is the the 52-week high and low of KOBO BIOTECH LIMITED shares ?
The 52-week high and low of KOBO BIOTECH LIMITED share is ₹9.99 and ₹1.99 as of 28 Jul, 2026.
What is the market cap of KOBO BIOTECH LIMITED?
The market capitalisation of KOBO BIOTECH LIMITED is ₹60.53 Crores as on 28 Jul, 2026.
What are the stock symbols of KOBO BIOTECH LIMITED?
The stock symbol of KOBO BIOTECH LIMITED is 531541 on the BSE, and the ISIN is INE881A01015.
How to buy KOBO BIOTECH LIMITED shares?
To buy KOBO BIOTECH LIMITED shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
What was yesterday's closing price for KOBO BIOTECH LIMITED shares ?
KOBO BIOTECH LIMITED shares closed yesterday at ₹8.73 on BSE
Can I buy KOBO BIOTECH LIMITED shares on Holidays?
No, shares of KOBO BIOTECH LIMITED or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell KOBO BIOTECH LIMITED shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.